AICAR
Price | Get Latest Price |
- Supply Ability:20tons
- Time:2022-07-14
Product Details
- Product NameAICAR
- CAS No.2627-69-2
- EINECS No.605-860-6
- MFC9H14N4O5
- MW258.23
- Appearancepowdertan
- storage temp. -20°C
- Melting point 214-215 °C
- Water Solubility Soluble in DMSO at 2mg/ml. Soluble in water or ethanol at less than 1mg/ml
- Boiling point 726.3±60.0 °C(Predicted)
- density 2.06±0.1 g/cm3(Predicted)
Acadesine (INN), also known as 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside, AICA-riboside, and AICAR, is an AMP-activated protein kinase activator which is used for the treatment of acute lymphoblastic leukemia and may have applications in treating other disorders such as diabetes.
Acadesine is an adenosine regulating agent developed by PeriCor Therapeutics and licensed to Schering-Plough in 2007 for phase III studies. The drug is a potential first-in-class agent for prevention of reperfusion injury in CABG surgery. Schering began patient enrollment in phase III studies in May, 2009. The trial was terminated in late 2010 based on an interim futility analysis.
Company Profile Introduction
- Since:2020-05-25
- Address: Zhanggeji Village, Fengjiazhai Town, Guangzong County, Xingtai City, Hebei Province